Health
Study finds Neuroprotectant delivered to the brain in nanoparticles may improve stroke treatment – NeuroNews International
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (17–19 March, virtual) has found that when NA1, a neuroprotectant,…
Jiangbing Zhou
Preliminary research to be presented at the International Stroke Conference (ISC) 2021 meeting (1719 March, virtual) has found that when NA1, a neuroprotectant, was delivered to the brain in nanoparticles, it reduced stroke severity and improved survival in a mouse model of stroke.
In an earlier human trial (the ESCAPE-NA1 trial), NA1, a small peptide designed to save brain cells from death after stroke, showed mixed results when NA1 was administered to patients undergoing clot removal…
-
Business13 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General21 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business12 hours agoHere’s what analysts expect for the BHP share price in the coming year